A self-amplifying mRNA COVID-19 vaccine drives potent and broad immune responses at low doses that protects non-human primates against SARS-CoV-2
A. R. Rappaport, S.-J. Hong, C. D. Scallan, L. Gitlin, A. Akoopie, G. R. Boucher, M. Egorova, J. A. Espinosa, M. Fidanza, M. A. Kachura, A. Shen, G. Sivko, A. Van Abbema, R. L. Veres, K. Jooss
This paper develops a self-amplifying mRNA vaccine that induces strong immune responses in mice and non-human primates, offering protection against SARS-CoV-2 at low doses.
bioRxiv · Nov 8, 2021 · PreprintImmunology